China Everbright Valuation
Is 165 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 165 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 165's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 165's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 165?
Other financial metrics that can be useful for relative valuation.
What is 165's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | HK$6.54b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 74.5x |
Enterprise Value/EBITDA | -20.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 165's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 15.6x | ||
1709 DL Holdings Group | 41.6x | n/a | HK$6.3b |
952 Quam Plus International Financial | 3.7x | n/a | HK$1.4b |
806 Value Partners Group | 5.3x | 10.7% | HK$3.1b |
211 Styland Holdings | 11.9x | n/a | HK$124.4m |
165 China Everbright | 21.3x | 77.7% | HK$6.5b |
Price-To-Sales vs Peers: 165 is expensive based on its Price-To-Sales Ratio (21.3x) compared to the peer average (15.6x).
Price to Earnings Ratio vs Industry
How does 165's PE Ratio compare vs other companies in the HK Capital Markets Industry?
Price-To-Sales vs Industry: 165 is expensive based on its Price-To-Sales Ratio (21.3x) compared to the Hong Kong Capital Markets industry average (2.4x).
Price to Sales Ratio vs Fair Ratio
What is 165's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 21.3x |
Fair PS Ratio | 3.3x |
Price-To-Sales vs Fair Ratio: 165 is expensive based on its Price-To-Sales Ratio (21.3x) compared to the estimated Fair Price-To-Sales Ratio (3.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.